Cefpodoxime Proxetil Tablet, Film Coated
NDC Package 69043-007-01
Package Information
Cefpodoxime Proxetil tablets is a medication used to treat a wide variety of bacterial infections. This formulation utilizes a tablet, film coated delivery system. Marketed by Cronus Pharma Llc, this product is identified by NDC 69043-007 and is authorized under FDA application ANDA065370.
Identification & Billing
- RxCUI: 309076 - cefpodoxime proxetil 100 MG Oral Tablet
- RxCUI: 309076 - cefpodoxime 100 MG Oral Tablet
- RxCUI: 309078 - cefpodoxime proxetil 200 MG Oral Tablet
- RxCUI: 309078 - cefpodoxime 200 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69043 - Cronus Pharma Llc
- 69043-007 - Cefpodoxime Proxetil
- 69043-007-01 - 100 TABLET, FILM COATED in 1 BOTTLE
- 69043-007 - Cefpodoxime Proxetil
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (69043-007). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69043-007-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Cefpodoxime Proxetil, a human prescription drug labeled by Cronus Pharma Llc. This tablet, film coated is formulated for oral use and contains cefpodoxime proxetil as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cronus Pharma Llc on June 11, 2007. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Cronus Pharma Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69043000701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.